13F filing recap · Q2 2012
What did Brave Warrior Advisors buy in Q2 2012?
Reported stock-position changes between this filing and the previous one.
Stock value
$1.41B
Positions
12
Estimated turnover
22.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Increased positions
VRXValeant Pharmaceuticals International, Inc.$236.85Mreported value+874.8K shares+19.8%GOOGLAlphabet Inc.$223.77Mreported value+62.3K shares+19.3%FISVFiserv Inc$162.94Mreported value+206.0K shares+10.1%CMPRCimpress Plc$126.83Mreported value+562.2K shares+16.7%ORCLOracle Corporation$118.99Mreported value+2.10M shares+110.7%MSIMotorola, Inc.$105.95Mreported value+300.4K shares+15.8%ONEHigher One Holdings, Inc.$94.08Mreported value+1.16M shares+17.7%ADBEAdobe Inc.$67.96Mreported value+657.9K shares+45.6%PRIPrimerica, Inc.$50.41Mreported value+183.4K shares+10.8%